Felipe
Villacampa Aubá
Consultor Médico
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (42)
2022
-
BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up
European Urology
-
Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial
World Journal of Urology, Vol. 40, Núm. 4, pp. 999-1004
2021
-
Quality of life and adverse events in patients with nonmuscle invasive bladder cancer receiving adjuvant treatment with BCG, MMC, or chemohyperthermia
Urologic Oncology: Seminars and Original Investigations, Vol. 39, Núm. 1, pp. 76.e9-76.e14
2020
-
Re: Inhibition of a G9a/DNMT Network Triggers Immune-Mediated Bladder Cancer Regression
Journal of Urology
-
Recomendaciones de manejo de la afectación renal en el complejo esclerosis tuberosa
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 40, Núm. 2, pp. 142-151
-
miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma
PloS one, Vol. 15, Núm. 2, pp. e0229075
2019
-
CDK4/6 inhibitor as a novel therapeutic approach for advanced bladder cancer independently of RB1 status
Clinical Cancer Research, Vol. 25, Núm. 1, pp. 390-402
-
Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status
Scientific Reports, Vol. 9, Núm. 1
-
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression
Nature Medicine
2018
-
Mitomycin C HIVEC. Update and results in high risk patients
Archivos Espanoles de Urologia, Vol. 71, Núm. 4, pp. 417-425
-
Programa formativo en cirugía endoscópica. Perspectivas de futuro
Archivos Espanoles de Urologia, Vol. 71, Núm. 1, pp. 89-96
-
Safety and efficacy of various strains of bacille Calmette-Guérin in the treatment of bladder tumours in standard clinical practice
Actas Urologicas Espanolas, Vol. 42, Núm. 4, pp. 238-248
-
Use of onabotulinum toxin A in patients with idiopathic overactive bladder and a lack of efficacy, intolerance or contraindication with anticholinergics
Urologia Colombiana, Vol. 27, Núm. 1, pp. 86-91
2017
-
BMP4 induces M2 macrophage polarization and favors tumor progression in bladder cancer
Clinical Cancer Research, Vol. 23, Núm. 23, pp. 7388-7399
-
Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer
Oncotarget, Vol. 8, Núm. 6, pp. 10531-10542
-
Tratamiento adyuvante intravesical en cáncer de vejiga no músculo invasivo: importancia de la cepa y el mantenimiento
Actas Urologicas Espanolas, Vol. 41, Núm. 9, pp. 590-595
-
UroMark—a urinary biomarker assay for the detection of bladder cancer
Clinical Epigenetics, Vol. 9, Núm. 1
-
Urothelial cancer proteomics provides both prognostic and functional information
Scientific Reports, Vol. 7, Núm. 1
2016
-
Everolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: A Spanish expanded access trial
Orphanet Journal of Rare Diseases, Vol. 11, Núm. 1
-
Recurrent aortitis associated with igG4-related disease
Circulation Journal, Vol. 80, Núm. 4, pp. 1041-1043